GB9412938D0 - Pharmaceutically active antioxidants - Google Patents

Pharmaceutically active antioxidants

Info

Publication number
GB9412938D0
GB9412938D0 GB9412938A GB9412938A GB9412938D0 GB 9412938 D0 GB9412938 D0 GB 9412938D0 GB 9412938 A GB9412938 A GB 9412938A GB 9412938 A GB9412938 A GB 9412938A GB 9412938 D0 GB9412938 D0 GB 9412938D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutically active
active antioxidants
antioxidants
pharmaceutically
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB9412938A
Other versions
GB2280110A (en
GB2280110B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Howard Foundation
Original Assignee
Howard Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939313266A external-priority patent/GB9313266D0/en
Application filed by Howard Foundation filed Critical Howard Foundation
Publication of GB9412938D0 publication Critical patent/GB9412938D0/en
Publication of GB2280110A publication Critical patent/GB2280110A/en
Application granted granted Critical
Publication of GB2280110B publication Critical patent/GB2280110B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB9412938A 1993-06-28 1994-06-28 Pharmaceutically-active hydrophilic carotenoid antioxidants Expired - Fee Related GB2280110B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939313266A GB9313266D0 (en) 1993-06-28 1993-06-28 Antioxidants for lipoproteins
US21989794A 1994-03-30 1994-03-30

Publications (3)

Publication Number Publication Date
GB9412938D0 true GB9412938D0 (en) 1994-08-17
GB2280110A GB2280110A (en) 1995-01-25
GB2280110B GB2280110B (en) 1997-11-12

Family

ID=26303133

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9412938A Expired - Fee Related GB2280110B (en) 1993-06-28 1994-06-28 Pharmaceutically-active hydrophilic carotenoid antioxidants

Country Status (4)

Country Link
AU (1) AU7005694A (en)
GB (1) GB2280110B (en)
IL (1) IL110139A0 (en)
WO (1) WO1995000130A1 (en)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329432B2 (en) 1993-06-28 2001-12-11 The Howard Foundation Mesozeaxanthin formulations for treatment of retinal disorders
GB2289406A (en) * 1994-04-15 1995-11-22 Britannia Health Products Ltd Vitamin, betacarotene and zinc composition for sperm health
US5527533A (en) * 1994-10-27 1996-06-18 Board Of Trustees Of The University Of Illinois Method of retarding and ameliorating central nervous system and eye damage
US6262109B1 (en) 1995-12-22 2001-07-17 Henkel Corporation Methods of preventing and/or treating high serum levels of cholesterol and/or lipids
WO1996019217A1 (en) * 1994-12-22 1996-06-27 Henkel Corporation Pharmaceutical compositions comprising lycopene
DK0831797T3 (en) * 1995-06-07 2007-04-02 Howard Foundation Pharmaceutically active carotenoids
JP2750281B2 (en) * 1995-06-15 1998-05-13 睦憲 藤原 Hypercholesterolemia treatment
JPH09124470A (en) 1995-10-26 1997-05-13 Suntory Ltd Antistress composition
US6140309A (en) * 1996-03-12 2000-10-31 University Of South Florida Vasoactive effects and free radical generation by β-amyloid peptides
WO1997048388A1 (en) * 1996-06-17 1997-12-24 The Board Of Trustees Of The University Of Illinois Method of retarding and ameliorating central nervous system and eye damage
IT1283143B1 (en) * 1996-07-12 1998-04-07 Indena Spa METHOD OF EXTRACTION OF THE LYCOPENE AND EXTRACTS THAT CONTAIN IT
EP0966960A1 (en) * 1996-11-27 1999-12-29 Dainippon Ink And Chemicals, Inc. Agent for inhibiting carcinogenesis or tumor metastasis
AU6141498A (en) * 1997-02-04 1998-08-25 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
SE522246C2 (en) 1997-02-27 2004-01-27 Astacarotene Ab Oral preparation for prophylactic and therapeutic treatment of Helicobacter Sp. infection
AU752468B2 (en) * 1997-04-04 2002-09-19 Phyllis E. Bowen Lutein esters having high bioavailability
SE512531C2 (en) * 1997-09-04 2000-03-27 Astacarotene Ab Use of at least one type of xanthophyll for the manufacture of a medicament for the prophylactic and / or therapeutic improvement of mammalian muscle function and / or treatment of mammalian muscle disorders or disorders
SE524337C2 (en) 1998-10-16 2004-07-27 Astacarotene Ab Use of at least one type of xanthophyll for the manufacture of a medicament for the prophylactic and / or therapeutic treatment of indigestion
NL1010351C2 (en) * 1998-10-19 2001-01-08 Werklust & Beheer B V Carotenoid esters for use in the prevention and treatment of eye diseases.
IL129442A0 (en) * 1999-04-14 2000-02-29 Lycored Natural Prod Ind Ltd Compounds useful in reducing the level of insulin like growth factor-1 (IGF-1) in blood
DE60033830T2 (en) * 1999-10-04 2007-11-15 John Harrow Carter PHARMACEUTICAL COMPOSITION CONTAINING COPPER, SALICYLIC ACID AND VITAMIN C
HU227182B1 (en) * 2000-03-06 2010-09-28 Andras Javor Lecitin-ascorbic acid combination
WO2002010770A2 (en) * 2000-07-31 2002-02-07 Neuronautics, Inc. Improved methods for identifying reagents which inhibit tau polymerization
GB2374008B (en) * 2001-04-04 2005-03-16 John Carter Pharmaceutical compositions comprising copper and zinc
GB0119052D0 (en) * 2001-08-03 2001-09-26 Mars Uk Ltd Foodstuff
GB0202900D0 (en) 2002-02-07 2002-03-27 Laxdale Ltd Novel formulations of drugs
US7351844B2 (en) 2002-02-25 2008-04-01 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
KR101017668B1 (en) * 2003-08-25 2011-02-25 디퓨젼 파마슈티컬즈 엘엘씨 Bipolar Trans Carotenoid Salts and Their Uses
US7351424B2 (en) 2004-07-22 2008-04-01 Bio Lut S.A. De C.V. Enhanced purity trans-lutein-ester compositions and methods of making same
JP2008531582A (en) 2005-02-24 2008-08-14 ディフュージョン・ファーマシューティカルズ・エルエルシー Trans carotenoids, their synthesis, formulation and use
JP5099812B2 (en) * 2006-04-07 2012-12-19 株式会社カネカ Blood sugar level rise inhibitor
JPWO2007116980A1 (en) * 2006-04-07 2009-08-20 国立大学法人 北海道大学 Blood sugar level rise inhibitor
US20070293568A1 (en) 2006-06-16 2007-12-20 Yamaha Hatsudoki Kabushiki Kaisha Neurocyte Protective Agent
JP5223083B2 (en) * 2006-06-21 2013-06-26 国立大学法人京都大学 Angiogenesis inhibitor
EA200970944A1 (en) 2007-04-13 2010-06-30 Диффьюжн Фармасьютикалз Ллс APPLICATION OF BIPOLAR TRANSCAROTINOIDS AS A PRELIMINARY TREATMENT IN THE TREATMENT OF PERIPHERAL VESSEL DISEASES
MX2010004803A (en) 2007-10-31 2010-09-09 Diffusion Pharmaceuticals Llc A new class of therapeutics that enhance small molecule diffusion.
CA2765697C (en) 2009-06-22 2019-11-12 Diffusion Pharmaceuticals Llc Diffusion enhancing compounds and their use alone or with thrombolytics
TWI492744B (en) 2009-12-04 2015-07-21 Abbott Lab Methods of modulating inflammation in preterm infants using carotenoids
EP2575487B1 (en) 2010-06-02 2017-10-18 Diffusion Pharmaceuticals Llc Oral formulations of bipolar trans carotenoids
CN103228276B (en) * 2010-09-30 2016-02-10 北京绿色金可生物技术股份有限公司 Application of fucoxanthin in preparation of product with neuroprotective effect related to neurodegenerative disease
WO2014155189A1 (en) 2013-03-28 2014-10-02 Omniactive Health Technologies Ltd. Neuroprotective effect of carotenoids in brain
KR20230014850A (en) 2016-03-24 2023-01-30 디퓨젼 파마슈티컬즈 엘엘씨 Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer
GB201618350D0 (en) * 2016-10-31 2016-12-14 Ip Science Ltd Methods and compositions comprising carotenoids

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH552388A (en) * 1970-07-10 1974-08-15 Hoffmann La Roche LIGHT PROTECTION AGENTS.
DE2923032A1 (en) * 1979-06-07 1980-12-11 Waldemar Hankin Pharmaceutical compsn. contg. heron egg yolk - for restoring balance between iron and gold in the blood
FR2558372B1 (en) * 1984-01-25 1987-08-07 Oreal DRUG COMPOSITION FOR THE TREATMENT OF ACNE
IL88961A (en) * 1988-01-29 1992-07-15 Basf Ag Stable mixtures containing oxidation-sensitive compounds
DE3812567A1 (en) * 1988-04-15 1989-10-26 Basf Ag METHOD FOR PRODUCING PHARMACEUTICAL MIXTURES
JP2619491B2 (en) * 1988-08-11 1997-06-11 サントリー株式会社 Astaxanthin-containing composition
DE69019035T2 (en) * 1989-02-28 1995-08-31 Nisshin Flour Milling Co Stabilized fat-soluble vitamin compositions.
IL90794A (en) * 1989-06-29 1995-03-15 Shapira Niva Nutritional sun-exposure supporting composition
DK546289D0 (en) * 1989-11-02 1989-11-02 Danochemo As carotenoid
CA2093008A1 (en) * 1990-10-01 1992-04-02 Charles H. Hennekens Beta-carotene and vitamin e therapy for inhibition of major vascular events
DE4141351A1 (en) * 1991-12-14 1993-06-17 Basf Ag STABLE POWDERFUL VITAMIN AND / OR CAROTINOIDE PREPARATES AND PROCESS FOR THEIR PREPARATION

Also Published As

Publication number Publication date
WO1995000130A1 (en) 1995-01-05
GB2280110A (en) 1995-01-25
AU7005694A (en) 1995-01-17
IL110139A0 (en) 1994-10-07
GB2280110B (en) 1997-11-12

Similar Documents

Publication Publication Date Title
GB9412938D0 (en) Pharmaceutically active antioxidants
ZA944633B (en) Pharmaceutically active antioxidants
GB9300119D0 (en) Pharmaceutically active compounds
GB9305660D0 (en) Pharmaceutically active compounds
GB9305661D0 (en) Pharmaceutically active compounds
GB9305997D0 (en) Pharmaceutically active compounds
GB9306767D0 (en) Pharmaceutically active compounds
GB9307741D0 (en) Pharmaceutically active compounds
GB9310462D0 (en) Pharmaceutically active compounds
GB9312879D0 (en) Pharmaceutically active compounds
GB9313105D0 (en) Pharmaceutically active compounds
GB9316806D0 (en) Pharmaceutically active compounds
GB9319835D0 (en) Pharmaceutically active compounds
GB9323344D0 (en) Pharmaceutically active compounds
GB9323345D0 (en) Pharmaceutically active compounds
GB9325410D0 (en) Pharmaceutically active compounds
GB9326512D0 (en) Pharmaceutically active compounds
GB9415620D0 (en) Pharmaceutically active compounds
GB9406729D0 (en) Pharmaceutically active compounds
GB9409372D0 (en) Pharmaceutically active compounds
GB9407826D0 (en) Pharmaceutically active compounds
GB9407080D0 (en) Pharmaceutically active compounds
GB9407017D0 (en) Pharmaceutically active compounds
GB9407000D0 (en) Pharmaceutically active compounds
GB9406999D0 (en) Pharmaceutically active compounds

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20010628